10 results
Myelodysplastic Syndrome (MD) - Diagnosis and Management Summary
myelo (marrow) -dys- (abnormal) -plastic (shape) = funny-shaped cells
dys- (abnormal) -plastic ... Hypomethylating agents ... only curative treatment ... #treatment #hematology ... #oncology
Aplastic Anemia - Overview

Who?
• M = F
• 3 peaks:	1) Childhood	2) 15-25 years	3) >60 years

What?
• Aplastic anemia
Headaches • Pale skin ... anemia Treatment ... #Anemia #oncology ... #hematology #diagnosis ... #management
Systemic Therapy for Hepatocellular Carcinoma - AGA Clinical Practice Guideline

First Line Treatment for HCC with Preserved
Hepatocellular Carcinoma ... Hepatocellular #Carcinoma ... #Management #Hepatology ... Gastroenterology #oncology ... #Pharmacology
Chronic Lymphocytic Leukemia - Summary

Cancer affecting lymphocytes/Mature B cell neoplasm
 • Lymphocytes accumulate in large numbers
• Exposure to Agent ... Hepatomegaly • Skin ... Pure red cell aplasia ... microglobulin Treatment ... #hematology
Myelodysplastic Syndromes (MDS)

What?
Myelodysplastic syndromes are a group of disorders caused by blood cells that are poorly
just beneath the skin ... Causes • Anemia • Aplastic ... Chemotherapeutic agents ... Syndromes #diagnosis #hematology ... #oncology
Antifungal agents benefits, weaknesses, and adverse effects in the treatment of Coccidioidomycosis
Fluconazole
 - Benefits: Low cost/tolerable
Antifungal agents ... effects in the treatment ... carcinoma, alopecia ... Coccidioidomycosis #pharmacology ... #management #treatment
Hodgkin's Lymphoma Overview

Hodgkin's lymphoma (HL) is an uncommon hematological malignancy arising from mature B cells. It
express many of the genes ... classical HL (MCHL ... Hodgkin Lymphoma Treatment ... classification #hematology ... #oncology #management
Overview of antifungal agents benefits, weaknesses, and adverse effects in the treatment of Coccidioidomycosis.
Fluconazole - Low
of antifungal agents ... effects in the treatment ... carcinoma, alopecia ... #valleyfever #management ... comparison #table #pharmacology
Anti-NXP-2 Dermatomyositis

What?
DM with generalized subcutaneous edema
Pts have more myalgias, more severe weakness, and an increased prevalence
have typical DM skin ... dorsal part of the MCP ... ulcerations • Skin ... positive patients Treatment ... Dermatomyositis #diagnosis #management
IDSA Recommendations for Preventing and Treating HHV-8 Diseases—Kaposi Sarcoma (KS), Primary Effusion Lymphoma (PEL), Multicentric Castleman’s
Castleman’s Disease (MCD ... involvement of skin ... • Antiviral agents ... #management #opportunistic ... infections #HIVAIDS #pharmacology